Literature DB >> 26617769

Demethylation of miR-10b plays a suppressive role in ccRCC cells.

Cheng He1, Xiaokun Zhao1, Hongyi Jiang1, Zhaohui Zhong1, Ran Xu1.   

Abstract

MicroRNAs have been implicated in cancer cells proliferation, migration and invasion, including clear-cell renal cell carcinoma (ccRCC). DNA methylation, a major epigenetic change associated with cancer, may lead to transcriptional silencing of tumor suppressor genes, including miRNAs, which may be a possible mechanism in carcinogenesis. In this study, we aim to investigate the role of miR-10b in ccRCC and its possible epigenetic mechanism. By qPCR and MSP, we found that miR-10b was significantly decreased in ccRCC tissues and cells, and exhibited heavy methylation on promoter. Upregulation of miR-10b by transfecting with lentivirus highly expressed miR-10b or by exogenous demethylation agents was capable of inhibiting cell proliferation, migration and invasion measured by CCK-8 cell proliferation assay, scratch assay, transwell assay, and flow cytometric analysis of the cell cycle. Our results suggest that miR-10b plays a tumor-suppressive role in ccRCC. Demethylation of miR-10b may be therapeutically beneficial for ccRCC treatment.

Entities:  

Keywords:  Clear-cell renal cell carcinoma; epigenetic; invasion; methylation; miR-10b; microRNA

Mesh:

Substances:

Year:  2015        PMID: 26617769      PMCID: PMC4637584     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  28 in total

1.  Expression of miRNAs involved in angiogenesis, tumor cell proliferation, tumor suppressor inhibition, epithelial-mesenchymal transition and activation of metastasis in bladder cancer.

Authors:  Apostolos Zaravinos; Jelena Radojicic; George I Lambrou; Dimitrios Volanis; Dimitris Delakas; Efstathios N Stathopoulos; Demetrios A Spandidos
Journal:  J Urol       Date:  2012-06-15       Impact factor: 7.450

2.  Epigenetic regulation of microRNA-10b and targeting of oncogenic MAPRE1 in gastric cancer.

Authors:  Kwoneel Kim; Han-Chul Lee; Jong-Lyul Park; Mirang Kim; Seon-Young Kim; Seung-Moo Noh; Kyu-Sang Song; Jin Cheon Kim; Yong Sung Kim
Journal:  Epigenetics       Date:  2011-06-01       Impact factor: 4.528

3.  Genome-wide aberrant DNA methylation of microRNA host genes in hepatocellular carcinoma.

Authors:  Jing Shen; Shuang Wang; Yu-Jing Zhang; Maya A Kappil; Hui Chen Wu; Muhammad G Kibriya; Qiao Wang; Farzana Jasmine; Habibul Ahsan; Po-Huang Lee; Ming-Whei Yu; Chien-Jen Chen; Regina M Santella
Journal:  Epigenetics       Date:  2012-09-13       Impact factor: 4.528

Review 4.  MicroRNAs in renal cell carcinoma: implications for pathogenesis, diagnosis, prognosis and therapy.

Authors:  Bader Mohamad Al-Ali; Anna Lena Ress; Armin Gerger; Martin Pichler
Journal:  Anticancer Res       Date:  2012-09       Impact factor: 2.480

5.  Identification of MicroRNAs associated with early relapse after nephrectomy in renal cell carcinoma patients.

Authors:  Ondrej Slaby; Martina Redova; Alexandr Poprach; Jana Nekvindova; Robert Iliev; Lenka Radova; Radek Lakomy; Marek Svoboda; Rostislav Vyzula
Journal:  Genes Chromosomes Cancer       Date:  2012-04-10       Impact factor: 5.006

6.  MicroRNA-10b is a prognostic indicator in colorectal cancer and confers resistance to the chemotherapeutic agent 5-fluorouracil in colorectal cancer cells.

Authors:  Naohiro Nishida; Shinya Yamashita; Koshi Mimori; Tomoya Sudo; Fumiaki Tanaka; Kohei Shibata; Hirofumi Yamamoto; Hideshi Ishii; Yuichiro Doki; Masaki Mori
Journal:  Ann Surg Oncol       Date:  2012-02-10       Impact factor: 5.344

7.  Tumour invasion and metastasis initiated by microRNA-10b in breast cancer.

Authors:  Li Ma; Julie Teruya-Feldstein; Robert A Weinberg
Journal:  Nature       Date:  2007-09-26       Impact factor: 49.962

8.  Identification of a 4-microRNA signature for clear cell renal cell carcinoma metastasis and prognosis.

Authors:  Xiwei Wu; Lihong Weng; Xuejun Li; Chao Guo; Sumanta K Pal; Jennifer M Jin; Yuping Li; Rebecca A Nelson; Bing Mu; Susan H Onami; Jeffrey J Wu; Nora H Ruel; Sharon P Wilczynski; Hanlin Gao; Maricela Covarrubias; Robert A Figlin; Lawrence M Weiss; Huiqing Wu
Journal:  PLoS One       Date:  2012-05-18       Impact factor: 3.240

9.  miR-10b*, a master inhibitor of the cell cycle, is down-regulated in human breast tumours.

Authors:  Francesca Biagioni; Noa Bossel Ben-Moshe; Giulia Fontemaggi; Valeria Canu; Federica Mori; Barbara Antoniani; Anna Di Benedetto; Raffaela Santoro; Sabrina Germoni; Fernanda De Angelis; Anna Cambria; Roi Avraham; Giuseppe Grasso; Sabrina Strano; Paola Muti; Marcella Mottolese; Yosef Yarden; Eytan Domany; Giovanni Blandino
Journal:  EMBO Mol Med       Date:  2012-11       Impact factor: 12.137

10.  Identification of metastamirs as metastasis-associated microRNAs in clear cell renal cell carcinomas.

Authors:  Zofia Wotschofsky; Julia Liep; Hellmuth-Alexander Meyer; Monika Jung; Ina Wagner; Alexander C Disch; Klaus D Schaser; Ingo Melcher; Ergin Kilic; Jonas Busch; Steffen Weikert; Kurt Miller; Andreas Erbersdobler; Hans-Joachim Mollenkopf; Klaus Jung
Journal:  Int J Biol Sci       Date:  2012-10-28       Impact factor: 6.580

View more
  6 in total

1.  MicroRNA-10b inhibits proliferation, migration and invasion in cervical cancer cells via direct targeting of insulin-like growth factor-1 receptor.

Authors:  Ren Hou; Daixian Wang; Jian Lu
Journal:  Oncol Lett       Date:  2017-04-13       Impact factor: 2.967

Review 2.  The Role of DNA Methylation in Renal Cell Carcinoma.

Authors:  Brittany N Lasseigne; James D Brooks
Journal:  Mol Diagn Ther       Date:  2018-08       Impact factor: 4.074

Review 3.  MicroRNA Signature in Renal Cell Carcinoma.

Authors:  Soudeh Ghafouri-Fard; Zeinab Shirvani-Farsani; Wojciech Branicki; Mohammad Taheri
Journal:  Front Oncol       Date:  2020-11-30       Impact factor: 6.244

4.  Sox2 induces glioblastoma cell stemness and tumor propagation by repressing TET2 and deregulating 5hmC and 5mC DNA modifications.

Authors:  Hernando Lopez-Bertoni; Amanda Johnson; Yuan Rui; Bachchu Lal; Sophie Sall; Maureen Malloy; Jonathan B Coulter; Maria Lugo-Fagundo; Sweta Shudir; Harmon Khela; Christopher Caputo; Jordan J Green; John Laterra
Journal:  Signal Transduct Target Ther       Date:  2022-02-09

Review 5.  Non-blood circulating tumor DNA detection in cancer.

Authors:  Muyun Peng; Chen Chen; Alicia Hulbert; Malcolm V Brock; Fenglei Yu
Journal:  Oncotarget       Date:  2017-08-04

6.  The critical role of BAP1 mutation in the prognosis and treatment selection of kidney renal clear cell carcinoma.

Authors:  Guobin Tan; Zijun Xuan; Zhiqin Li; Shuitong Huang; Guangming Chen; Yonglu Wu; Xianxi Chen; Zhijin Liang; Aiming Wu
Journal:  Transl Androl Urol       Date:  2020-08
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.